Lifecore Biomedical, Inc. \de\ SEC filings LFCR
Lifecore Biomedical, Inc. \de\ has 1,005 filings in SEC EDGAR's recent list, going back to May 16, 2012. Its latest annual report, Form 10-KT, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on May 25.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Nov 5, 2026 | — |
| 8-K |
Current report
Other events
|
Nov 5, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| PREM14A | Filing | Oct 30, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Other events
|
Oct 20, 2026 | Oct 16, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 29, 2026 | — |
| 8-K |
Current report
Material agreement
|
Sep 29, 2026 | Sep 24, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 28, 2026 | — |
| DEFA14A | Additional proxy material | Sep 28, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 28, 2026 | Sep 27, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 2, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 2, 2026 | Jun 29, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 2, 2026 | — |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2026 | May 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Apr 24, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 14, 2026 |
| 10-KT | Transition report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 16, 2026 | Mar 16, 2026 |
| 8-K | Current report | Mar 5, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Mar 2, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jan 16, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 17, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Oct 31, 2025 | Oct 29, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 17, 2025 | — |
| EFFECT | Filing | Sep 30, 2025 | — |
| 424B3 | Prospectus | Sep 30, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2025 | Sep 22, 2025 |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2025 | — |
| S-3 | Shelf registration | Sep 23, 2025 | — |
| DEF 14A | Proxy statement | Sep 18, 2025 | Sep 18, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Auditor change
|
Aug 18, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 12, 2025 | Aug 12, 2025 |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| 10-K | Annual report | Aug 7, 2025 | May 25, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 18, 2025 | Jul 15, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 8, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 8, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 8, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 29, 2025 | — |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 12, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2025 | Apr 11, 2025 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 14, 2025 |
| 3 | Initial insider ownership | Apr 16, 2025 | Apr 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 10, 2025 | Apr 10, 2025 |
| 10-Q | Quarterly report | Apr 3, 2025 | Feb 23, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 3, 2025 | Apr 3, 2025 |
| DEF 14A | Proxy statement | Feb 27, 2025 | Feb 27, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| PRE 14A | Preliminary proxy statement | Jan 21, 2025 | Jan 21, 2025 |
| DEFA14A | Additional proxy material | Jan 17, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 17, 2025 | Jan 17, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2025 | Jan 7, 2025 |
| 10-Q | Quarterly report | Jan 2, 2025 | Nov 24, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 2, 2025 | Jan 2, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 26, 2024 | — |
| 4 | Insider transaction | Dec 10, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 6, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 26, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 21, 2024 | Nov 21, 2024 |
| 144 | Notice of proposed sale | Nov 20, 2024 | — |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 8, 2024 | Nov 7, 2024 |
| 144 | Notice of proposed sale | Oct 31, 2024 | — |
| 4 | Insider transaction | Oct 29, 2024 | Oct 7, 2024 |
| 424B3 | Prospectus | Oct 23, 2024 | — |
| EFFECT | Filing | Oct 22, 2024 | — |
| CORRESP | Letter to the SEC | Oct 18, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2024 | — |
| EFFECT | Filing | Oct 15, 2024 | — |
| S-8 | Employee stock plan registration | Oct 10, 2024 | — |
| S-8 | Employee stock plan registration | Oct 10, 2024 | — |
| S-1 | Registration statement | Oct 10, 2024 | — |
| POS AM | Filing | Oct 10, 2024 | — |
| 4 | Insider transaction | Oct 7, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 3, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 7, 2024 | — |
| 144 | Notice of proposed sale | Oct 7, 2024 | — |
| 10-Q | Quarterly report | Oct 4, 2024 | Aug 25, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Oct 4, 2024 | Oct 3, 2024 |
| DEF 14A | Proxy statement | Sep 23, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 23, 2024 | Sep 23, 2024 |
| 144 | Notice of proposed sale | Sep 20, 2024 | — |
| 4/A | Form 4/a | Sep 16, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Other events
|
Sep 12, 2024 | Sep 11, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 3 | Initial insider ownership | Sep 5, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Aug 29, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 26, 2024 | Aug 26, 2024 |
| 10-K | Annual report | Aug 26, 2024 | May 26, 2024 |
| 4 | Insider transaction | Aug 22, 2024 | Aug 19, 2024 |
| 3 | Initial insider ownership | Aug 22, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 21, 2024 | Aug 19, 2024 |
| 4 | Insider transaction | Aug 21, 2024 | Aug 19, 2024 |
| 4 | Insider transaction | Aug 21, 2024 | Aug 19, 2024 |
| 3 | Initial insider ownership | Aug 21, 2024 | Aug 15, 2024 |
| 3 | Initial insider ownership | Aug 21, 2024 | Aug 15, 2024 |
| 3 | Initial insider ownership | Aug 21, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Aug 21, 2024 | Aug 15, 2024 |
| NT 10-K | Filing | Aug 12, 2024 | May 26, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Feb 25, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Nov 26, 2023 |
| 10-Q | Quarterly report | Aug 9, 2024 | Aug 27, 2023 |
| DEFA14A | Additional proxy material | Aug 9, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2024 | Jul 18, 2024 |
| DEF 14A | Proxy statement | Jul 19, 2024 | May 28, 2023 |
| 8-K |
Current report
Exit or restructuring costs
|
Jul 12, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jul 10, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jul 10, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jul 10, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jul 10, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jul 10, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jul 10, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jul 10, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jul 10, 2024 | Jul 8, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 8, 2024 | May 28, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 5, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 1, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 1, 2024 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Jul 1, 2024 | Jun 28, 2024 |
| UPLOAD | Letter from the SEC | Jun 13, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 11, 2024 | — |
| 8-K |
Current report
Listing notice
|
Jun 7, 2024 | Jun 3, 2024 |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| 4 | Insider transaction | May 22, 2024 | May 20, 2024 |
| 3 | Initial insider ownership | May 22, 2024 | May 20, 2024 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
May 22, 2024 | May 19, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | May 20, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 16, 2024 | May 16, 2024 |
| 8-K |
Current report
Material agreement, Listing notice
|
May 14, 2024 | May 8, 2024 |
| UPLOAD | Letter from the SEC | May 13, 2024 | — |
| 8-K |
Current report
Material agreement
|
May 8, 2024 | May 2, 2024 |
| 8-K |
Current report
Officer or director change
|
May 7, 2024 | May 1, 2024 |
| 8-K |
Current report
Auditor change
|
Apr 30, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Apr 19, 2024 | Apr 15, 2024 |
| NT 10-Q | Filing | Apr 8, 2024 | Feb 25, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Auditor change
|
Mar 26, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 21, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2024 | Mar 20, 2024 |
| 10-K | Annual report | Mar 20, 2024 | May 28, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 29, 2024 | — |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Feb 16, 2024 | Feb 13, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Jan 22, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jan 12, 2024 | Jan 10, 2024 |
| 4 | Insider transaction | Jan 10, 2024 | Jan 9, 2024 |
| NT 10-Q | Filing | Jan 10, 2024 | Nov 26, 2023 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jan 5, 2024 | Dec 31, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Restatement
|
Oct 31, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 18, 2023 | Oct 12, 2023 |
| NT 10-Q | Filing | Oct 10, 2023 | Aug 27, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 31, 2023 | Aug 31, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LFCR (Nasdaq)
- Fiscal year ends
- May 25
- Incorporated in
- DE
- Headquarters
- Chaska, MN
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1005286
- Former names
- LANDEC CORP \CA\ (until Nov 7, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.